Eventide Asset Management - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 163 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$18,400,020
+3.1%
898,0000.0%0.33%
+9.6%
Q2 2023$17,843,260
+16.0%
898,0000.0%0.30%
+7.1%
Q1 2023$15,382,740
+67.0%
898,000
+90.8%
0.28%
+54.9%
Q4 2022$9,210,699
-74.0%
470,654
-69.6%
0.18%
-73.8%
Q3 2020$35,433,000
+9.2%
1,550,0000.0%0.69%
-1.6%
Q2 2020$32,442,000
+64.4%
1,550,000
+9.5%
0.70%
+10.3%
Q1 2020$19,739,000
-38.7%
1,415,0000.0%0.64%
-29.5%
Q4 2019$32,205,000
+95.4%
1,415,0000.0%0.91%
+66.4%
Q3 2019$16,485,000
+10.5%
1,415,000
+42.3%
0.54%
+20.3%
Q2 2019$14,915,000
+20.0%
994,314
+40.3%
0.45%
+5.8%
Q1 2019$12,429,000
+18.4%
708,6000.0%0.43%
-8.0%
Q4 2018$10,501,000
+8.1%
708,600
+79.6%
0.46%
+30.3%
Q3 2018$9,715,000
+25.4%
394,5850.0%0.36%
+11.2%
Q2 2018$7,746,000
+4.7%
394,5850.0%0.32%
-7.2%
Q1 2018$7,398,000394,5850.35%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 523,280$10,722,00712.30%
RTW INVESTMENTS, LP 17,687,772$362,422,4487.65%
Logos Global Management LP 1,975,000$40,467,7505.40%
ACUTA CAPITAL PARTNERS, LLC 362,000$7,417,3804.97%
New Leaf Venture Partners, L.L.C. 118,242$2,422,7793.11%
MAVERICK CAPITAL LTD 5,629,970$115,358,0852.60%
Ghost Tree Capital, LLC 295,000$6,044,5501.99%
Frazier Life Sciences Management, L.P. 1,403,013$28,747,7361.91%
Ikarian Capital, LLC 654,726$13,415,3351.61%
Boxer Capital, LLC 1,466,051$30,039,3851.60%
View complete list of ROCKET PHARMACEUTICALS INC shareholders